<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In subjects with <z:hpo ids='HP_0001677'>coronary artery diseases</z:hpo> (obstructive and vasospastic <z:hpo ids='HP_0001681'>angina pectoris</z:hpo> (AP)) who have no <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0001513'>obesity</z:hpo> and physical inactivity, insulin sensitivity was significantly reduced with compensated <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> on OGTT </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> significantly correlated with <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> score </plain></SENT>
<SENT sid="2" pm="."><plain>In vasospastic AP (VAP), those who fulfilled more than 3 risk factors out of 5 (<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>) consist of 70 and 40% for smokers and nonsmokers respectively </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> syndrome who fulfilled <z:hpo ids='HP_0000001'>all</z:hpo> the criteria was 9-10% for VAP </plain></SENT>
<SENT sid="4" pm="."><plain>In atherothrombotic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (ATTI) with the same exclusion criteria, the similar <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> have been observed, but not in embolic (cardiac origin) or <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In ATTI, high TG and apo B with low <z:chebi fb="17" ids="39025">HDL</z:chebi>-chol were noted in blood </plain></SENT>
<SENT sid="6" pm="."><plain>In essential <z:hpo ids='HP_0000822'>hypertension</z:hpo> without <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> was noted in 25-35% and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in 56-88% </plain></SENT>
<SENT sid="7" pm="."><plain>Reduction of blood pressure with alpha blocker (bunazosin), <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi> (cilazapril), long-acting <z:chebi fb="1" ids="39099">Ca+</z:chebi>+ blocker (<z:chebi fb="0" ids="2668">amlodipine</z:chebi>) significantly improved lowered insulin sensitivity </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> rather than <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> is more closely associated with blood pressure </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular diseases</z:e> (vasospastic and obstructive AP, brain cortical artery diseases) are prone to develop <z:mp ids='MP_0002055'>diabetes</z:mp> because of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and also promote the generation of cumulative risk factors resulting in a vicious cycle </plain></SENT>
<SENT sid="10" pm="."><plain>Efforts to alleviate <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is crucial for the primary and secondary prevention of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
</text></document>